Differential retinoic acid signaling in tumors of long-and short-term glioblastoma survivors
S Barbus, B Tews, D Karra, M Hahn… - Journal of the …, 2011 - academic.oup.com
Although the prognosis of most glioblastoma patients is poor, 3%–5% patients show long-
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
[PDF][PDF] Differential Retinoic Acid Signaling in Tumors of Long-and Short-term Glioblastoma Survivors
S Barbus, B Tews, D Karra, M Hahn… - JNCI: Journal of …, 2011 - research-collection.ethz.ch
DOI: 10.1093/jnci/djr036© The Author 2011. Published by Oxford University Press. All rights
reserved. Advance Access publication on February 23, 2011. For Permissions, please e …
reserved. Advance Access publication on February 23, 2011. For Permissions, please e …
Differential Retinoic Acid Signaling in Tumors of Long-and Short-term Glioblastoma Survivors.
S Barbus, B Tews, D Karra, M Hahn… - JNCI: Journal of the …, 2011 - search.ebscohost.com
Although the prognosis of most glioblastoma patients is poor, 3%–5% patients show long-
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
Differential retinoic acid signaling in tumors of long-and short-term glioblastoma survivors.
S Barbus, B Tews, D Karra, M Hahn… - Journal of the …, 2011 - europepmc.org
Although the prognosis of most glioblastoma patients is poor, 3%-5% patients show long-
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
[PDF][PDF] Differential Retinoic Acid Signaling in Tumors of Long-and Short-term Glioblastoma Survivors
S Barbus, B Tews, D Karra, M Hahn… - J Natl Cancer …, 2011 - researchgate.net
Although the prognosis of most glioblastoma patients is poor, 3%–5% patients show long-
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
[PDF][PDF] Differential retinoic acid signaling in tumors of long-and short-term glioblastoma survivors
S Barbus, B Tews, D Karra, M Hahn… - J Natl Cancer …, 2011 - scholar.archive.org
Although the prognosis of most glioblastoma patients is poor, 3%-5% patients show long-
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
Differential retinoic acid signaling in tumors of long-and short-term glioblastoma survivors
SL Bărbuş, B Tews, D Karra, M Hahn, B Radlwimmer… - 2011 - katalog.ub.uni-heidelberg.de
Although the prognosis of most glioblastoma patients is poor, 3%-5% patients show long-
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
Differential Retinoic Acid Signaling in Tumors of Long-and Short-term Glioblastoma Survivors
S Barbus, B Tews, D Karra, M Hahn… - JNCI: Journal of the …, 2011 - publications.slu.se
Although the prognosis of most glioblastoma patients is poor, 3%-5% patients show long-
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
[HTML][HTML] Differential Retinoic Acid Signaling in Tumors of Long-and Short-term Glioblastoma Survivors
S Barbus, B Tews, D Karra, M Hahn… - Journal of the National …, 2011 - doc.rero.ch
Although the prognosis of most glioblastoma patients is poor, 3%–5% patients show long-
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
Differential retinoic acid signaling in tumors of long-and short-term glioblastoma survivors.
S Barbus, B Tews, D Karra, M Hahn… - Journal of the National …, 2011 - diva-portal.org
Although the prognosis of most glioblastoma patients is poor, 3%-5% patients show long-
term survival of 36 months or longer after diagnosis. To study the differences in activation of …
term survival of 36 months or longer after diagnosis. To study the differences in activation of …